{"result": {"id": "chatcmpl-617", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **CLINICAL** study investigated the clinical features of eyes with unilateral type 3 macular neovascularization, examining both the clinical setting and the specific characteristics of these patients. The study focused on anti-angiogenic drugs as a potential treatment for this condition.  \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743240786, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 54, "prompt_tokens": 189, "total_tokens": 243, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"CLINICAL\"\nDescription List: [\"Clinical trials for anti-angiogenic drugs\", \"The **CLINICAL** study focused on the clinical features of eyes with unilateral type 3 macular neovascularization.  This study also examined the clinical setting in which the research was conducted. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_e7ef61913441213b6bae01de3c1e3570f4f692b2e5f6fb650f32d1889bc9698c_v2"}